Anaplastic thyroid carcinoma: Diagnosis-kital and treatment;Il carcinoma anaplastico della tiroide: Inquadramento diagnostico e attuali possibilità terapeutiche

Clinica Terapeutica

Volumn 152, Issue 4, 2001, Pages 255-261

  Giuffrida, D ^a   Lavenia, G ^a   Aiello, R A ^a   Di Blasi, C ^a   Gambera, G ^a   Pappalardo, A ^a   Petralia, G ^a   Ursino, M ^a   Failla, G ^a  

^a SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

Anaplastic cancer; Chemotherapy; p53 mutation; Thyroid neoplasm

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN A2; CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MITOXANTRONE; PEPLEOMYCIN; PROTEIN P53; RADIOACTIVE IODINE; THYROGLOBULIN; VINBLASTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; GENE MUTATION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MONOTHERAPY; REVIEW; SURVIVAL RATE; SURVIVAL TIME; THYROID CARCINOMA; TREATMENT PLANNING;

CARCINOMA; HUMANS; THYROID NEOPLASMS;

EID: 0034773832     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. The epidemiology of thyroid carcinoma
2. Thyroid cancer of follicular cell origin
3. Natural history, treatment, and course of papillary thyroid carcinoma
4. Well-differentiated thyroid carcinoma and the results of various modalities of treatment. A retrospective review of 1599 patients
5. Prognosis of thyroid carcinoma
6. Anaplastic thyroid carcinoma: Behavior, biology, and therapeutic approaches
7. Anaplastic carcinoma of the thyroid: A review of 84 cases of spindle and giant cell carcinoma of the thyroid
8. Anaplastic thyroid carcinoma: Current diagnosis and treatment
9. Prognostic factors for thyroid carcinoma. A population-based study of 15.698 cases from the surveillance, epidemiology and end results (SEER) program
10. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area
11. The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma
12. Undifferentiated and poorly differentiated carcinoma
13. Undifferentiated or anaplastic carcinoma of the thyroid
14. Anaplastic carcinoma following well-differentiated thyroid cancer: Etiological considerations
15. Anaplastic transformation of metastatic follicular carcinoma of the thyroid
16. p53 gene mutatios associated with anaplastic trasformation of human thyroid carcinomas
17. High prevalence of mutations of the p53 gene in poorly differentiated thyroid carcinomas
18. Immunohistochemical detection of p53 in differentiated and undifferentiated carcinomas of the thyroid
19. Cd97: A dedifferentiation marker in human thyroid carcinomas
20. Frequent mutation and nuclar localization of beta -catenin in anaplastic thiroid carcinoma
21. Cytokine production by a new undifferentiated human thyroid cancer cell line, FB-1
22. Establishment of a human undifferentiated thyroid cancer cell line producing several growth factors and cytokines
23. Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): Report of a case
24. Anaplastic thiroid carcinoma with prominent cardiac metastasis, accompanied by a marked leukocitosis with a neutrofilia and high GMCSF level in serum
25. Anaplastic thyroid carcinoma. A study of 70 cases
26. Anaplastic thiroid carcinoma: Cytomorphology and clinical implications of fine needle aspirations
27. Anaplastic thyroid carcinoma. Immunocitochemical study of 32 cases
28. Anaplastic thyroid carcinoma. A clinical, histologic, and immunohistochemical study
29. Thyroid carcinosarcoma, a rare and aggressive histotype: A case report
30. Immunohistochemical analysis of small-celll tumors of the thyroid gland: An Eastern Cooperative Oncology Group study
31. Immunohistochemical reclassification of anaplastic carcinoma reveals small and giant cell lynphoma
32. Uncommon types of thyroid cancer
33. Cardiac metastases from primary anaplastic thyroid carcinoma: Report of three cases and a review of the literature
34. A presentation of anaplastic carcinoma of the thyroid with symptomatic intra-abdominal metastases
35. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases
36. Anaplastic carcinoma of the thyroid: A clinicopathologic study of 82 cases
37. Treatment guidelines for patients with thyroid nodules and well differentiated thyroid cancer
38. Current management of thyroid cancer
39. CT evaluation of anaplastic thyroid carcinoma
40. Treatment of 37 patients with anaplastic carcinoma of the thyroid
41. Anaplastic carcinoma of the thyroid gland treated by radiation therapy
42. Anaplastic thyroid carcinoma: A new approach
43. Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma
44. Anaplastic thyroid carcinoma: Ninety-one patients treated by surgery and radiotherapy
45. Anaplastic thyroid carcinoma: Risk factors and outcome
46. Phase II evaluation of high-dose accelerated radiotherapy for anaplastic thyroid carcinoma
47. Treatment of anaplastic giant and spindle-cell carcinoma of the tyroid gland with combination adriamycin and radiation therapy. A new approach
48. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy
49. Anaplastic thyroid carcinoma. Doxorubicin, hyperfractionated radiotherapy and surgery
50. Combined doxorubicin, hyperfractionated radiotherapy, and surgery, in anaplastic thyroid carcinoma: Report on two protocols
51. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma
52. Treatment of refractory thyroid cancer with adriamycin
53. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma
54. Chemotherapy of thyroid carcinoma
55. Combined chemotherapy with bleomicin, adriamycin, and platinum, in advanced thyroid cancer
56. Intensive chemotherapy for anaplastic thyroid carcinoma. Combination of cisplatin doxorubicin, etoposide, and peplomycin with granulocyte colony-stimulating factor support
57. Results of combined modality treatment in poorly differentiated and anaplastic thyroid carcinoma
58. Thyroid cancer: Different outcomes to chemotherapy according to tumor histology
59. Undifferentiated thyroid carcinoma and unusual thyroid malignancies
60. Multimodality treatment in anaplastic giant cell thyroid carcinoma
61. Multimodal therapy in anaplastic giant cell thyroid carcinoma
62. Anaplastic thyroid carcinoma: Retrospective analysis of 34 patients treated with external radiotherapy (R), chemotherapy (C), or both (R+C)
63. Combination therapy for anaplastic giant-cell thyroid carcinoma
64. Anaplastic carcinoma of the thyroid
65. Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo
66. Treatment of anaplastic thyroid carcinoma with paclitaxel: Phase 2 trial using ninety-six-hour infusion